These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5052 related articles for article (PubMed ID: 6273486)

  • 21. Analysis of cyclic nucleotide phosphodiesterase(s) by radioimmunoassay.
    Sarada K; Epstein PM; Strada SJ; Thompson WJ
    Arch Biochem Biophys; 1982 Apr; 215(1):183-98. PubMed ID: 6284039
    [No Abstract]   [Full Text] [Related]  

  • 22. Activity of cyclic nucleotide phosphodiesterases in granulocytes of chronic myelogenous leukemia (CML). A preliminary report.
    Naskalski JW; Uciński WS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):134-40. PubMed ID: 2581858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultracytochemical localizations of adenylate cyclase, guanylate cyclase and cyclic 3',5'-nucleotide phosphodiesterase activity on the trophoblast in the human placenta. Direct histochemical evidence.
    Matsubara S; Tamada T; Saito T
    Histochemistry; 1987; 87(6):505-9. PubMed ID: 2891656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of cyclic nucleotide phosphodiesterase in mouse brain.
    Yang MS; Passonneau P; Lowry OH
    J Neurochem; 1981 Mar; 36(3):1272-8. PubMed ID: 6259285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic nucleotide phosphodiesterase in the aorta of spontaneously hypertensive rats : variation with age and effect of propranolol.
    Bucher B; Stoclet JC
    Artery; 1980; 7(1):44-55. PubMed ID: 6264899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective adsorption of 2'-O-anthraniloyl-AMP on DEAE-Sephadex: the basis of a direct, fluorescent assay for cyclic nucleotide phosphodiesterase.
    Karuppiah N; Mutus B
    Anal Biochem; 1985 Aug; 149(1):202-8. PubMed ID: 3000214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclic AMP metabolism in pigeon arteries: comparison of atherosclerotic-resistant and -susceptible strains.
    Singer AL; Brodie AF
    J Mol Cell Cardiol; 1978 Apr; 10(4):347-61. PubMed ID: 205658
    [No Abstract]   [Full Text] [Related]  

  • 29. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
    Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
    Dunkern TR; Hatzelmann A
    Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclic 3':5'-adenosine monophosphate phosphodiesterase and cyclic 3':5'-guanosine monophosphate phosphodiesterase of normal granulocytes and granulocytes of chronic myelogenous leukaemia.
    Uciński WS; Naskalski JW
    Haematologia (Budap); 1986; 19(4):275-83. PubMed ID: 3028916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose exerts opposite effects on mRNA versus protein and activity levels of Pde1, the low-affinity cAMP phosphodiesterase from budding yeast, Saccharomyces cerevisiae.
    Wera S; Ma P; Thevelein JM
    FEBS Lett; 1997 Dec; 420(2-3):147-50. PubMed ID: 9459299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Qualitative and quantitative MS analysis of cyclic nucleotides and related enzymes.
    Newton RP
    Biochem Soc Trans; 1996 Aug; 24(3):938-43. PubMed ID: 8878878
    [No Abstract]   [Full Text] [Related]  

  • 34. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis.
    Piazza GA; Thompson WJ; Pamukcu R; Alila HW; Whitehead CM; Liu L; Fetter JR; Gresh WE; Klein-Szanto AJ; Farnell DR; Eto I; Grubbs CJ
    Cancer Res; 2001 May; 61(10):3961-8. PubMed ID: 11358813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phosphodiesterases of cyclic GMP].
    Wróblewska H; Gorczyca WA
    Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
    White JB; Thompson WJ; Pittler SJ
    Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Taste bud adenosine -3'5'-monophosphate phosphodiesterase: activity, subcellular distribution and kinetic parameters.
    Law JS; Henkin RI
    Res Commun Chem Pathol Pharmacol; 1982 Dec; 38(3):439-52. PubMed ID: 6298918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries.
    Birk S; Edvinsson L; Olesen J; Kruuse C
    Eur J Pharmacol; 2004 Apr; 489(1-2):93-100. PubMed ID: 15063160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 253.